Breaking News Instant updates and real-time market news.

2020-03-17 16:17:09 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 16:17 03/17/20 03/17 16:17 03/17/20 16:17	NASDAQ market internals summary Volume was above average for this time of day. Breadth was mixed with issues and volume bullish while new highs to new lows were bearish (negative divergence). Advancing Issues: 2209 / Declining Issues: 1129 -- for a ratio of 2 to 1. Advancing Volume: 3,349,189,000 / Declining Volume: 1,419,670,000 -- for a ratio of 2.4 to 1. New 52-Week Highs: 13 / New 52-Week Lows: 1132.

2020-03-17 16:17:09

$NSD

NASDAQ Market Internals

$0.00 / + (+0.00%)

16:17

03/17/20

03/17

16:17

03/17/20

16:17

NASDAQ market internals summary

Volume was above average for this time of day. Breadth was mixed with issues and volume bullish while new highs to new lows were bearish (negative divergence). Advancing Issues: 2209 / Declining Issues: 1129 -- for a ratio of 2 to 1. Advancing Volume: 3,349,189,000 / Declining Volume: 1,419,670,000 -- for a ratio of 2.4 to 1. New 52-Week Highs: 13 / New 52-Week Lows: 1132.

TODAY'S FREE FLY STORIES

On The Fly	Bed Bath & Beyond up again as UBS says sell, take profits after rally » 10:42 01/26/21 01/26 10:42 01/26/21 10:42 BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) , BB BlackBerry $18.48 / +0.44 (+2.44%) , FB Facebook $281.99 / +3.98 (+1.43%) Shares of Bed Bath &… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 01/19/21 Bed Bath & Beyond completes sale of Cost Plus World Market to Kingswood 01/07/21 Bed Bath & Beyond drops 11% to $18.61 after Q3 results, guidance miss estimates 01/07/21 Bed Bath & Beyond: Guidance assumes flat comparable sales in FY21 01/07/21 Bed Bath & Beyond: Digital comp sales up 94% in Q3, store comp sales down 14% BB BlackBerry $18.48 / +0.44 (+2.44%) 05:45 Today BlackBerry, Baidu expand partnership for autonomous driving technology 01/25/21 BlackBerry rises 34.4% 01/25/21 BlackBerry 'not aware' of any material, undisclosed corporate developments 01/25/21 BlackBerry rises 39.8% FB Facebook $281.99 / +3.98 (+1.43%) 01/21/21 Facebook: Trump's access to remain suspended 'indefinitely' 01/21/21 Facebook referrering former President Trump's suspension to Oversight Board 01/11/21 Facebook to remove content containing phrase 'stop the steal' 01/11/21 Airbnb says its PAC will 'withhold support' from those who opposed certification BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 09:53 Today Fly Intel: Top five analyst downgrades 07:47 Today Bed Bath & Beyond downgraded to Sell at UBS after recent run-up in stock 07:19 Today Raymond James Bed Bath & Beyond downgraded to Market Perform from Strong Buy at Raymond James 06:43 Today UBS Bed Bath & Beyond downgraded to Sell from Neutral at UBS BB BlackBerry $18.48 / +0.44 (+2.44%) 09:53 Today Fly Intel: Top five analyst downgrades 05:11 Today RBC Capital BlackBerry downgraded to Underperform from Sector Perform at RBC Capital 12/18/20 TD Securities BlackBerry price target raised to $8.50 from $5.50 at TD Securities 12/15/20 RBC Capital BlackBerry price target raised to $7.50 from $5 at RBC Capital FB Facebook $281.99 / +3.98 (+1.43%) 08:31 Today Morgan Stanley Morgan Stanley work finds 'modestly rising' U.S. use of IG Shopping and Reels 07:02 Today Deutsche Bank Deutsche ups Facebook target to $350, sees upcoming Q4 as 'clearing event' 04:53 Today Piper Sandler Facebook Q4 results Wednesday should be 'strong,' says Piper Sandler 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 01/07/21 Bed Bath & Beyond sees FY21 revenue $8B-$8.2B, consensus $9.61B 01/07/21 Bed Bath & Beyond sees Q4 revenue down double-digit percent, consensus $2.92B 01/07/21 Bed Bath & Beyond reports Q3 adjusted EPS 8c, consensus 19c 01/06/21 Notable companies reporting before tomorrow's open BB BlackBerry $18.48 / +0.44 (+2.44%) 12/17/20 BlackBerry reports Q3 adjusted EPS 2c, consensus (1c) 09/24/20 BlackBerry reports Q2 non-GAAP EPS 11c, consensus 2c FB Facebook $281.99 / +3.98 (+1.43%) 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 10/29/20 Facebook reports Q3 EPS $2.71, consensus $1.91 10/29/20 Notable companies reporting after market close 07/30/20 Facebook reports Q2 EPS $1.80, consensus $1.39 BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 10/08/20 Legion's Kiper pitches OneSpan, Bed Bath as long ideas, Bloomberg reports BB BlackBerry $18.48 / +0.44 (+2.44%) 01/15/21 BlackBerry reports settlement with Facebook over patents, Bloomberg says FB Facebook $281.99 / +3.98 (+1.43%) 01/23/21 Big tech stocks are back, Barron's says 01/22/21 Facebook memo told employees to prioritize privacy, OneZero reports 01/21/21 Apple's first headset to focus on virtual reality, Bloomberg reports 01/20/21 Facebook rival MeWe adds 2.5M privacy-seeking users in a week, USA Today says BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 10:05 Today Comcast upgrade, Bed Bath & Beyond downgrade among top calls on Wall Street 01/25/21 Fly Intel: Wall Street's top stories for Monday 01/25/21 Fly Intel: Wall Street's top stories at midday 01/07/21 Fly Intel: Wall Street's top stories for Thursday BB BlackBerry $18.48 / +0.44 (+2.44%) 01/25/21 Fly Intel: Wall Street's top stories at midday 01/20/21 #SocialStocks: Facebook could be in focus under new administration 12/17/20 Fly Intel: After-Hours Movers 12/01/20 Fly Intel: Wall Street's top stories for Tuesday FB Facebook $281.99 / +3.98 (+1.43%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/19/21 Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades 01/19/21 Facebook upgrade, Roku initiation among today's top calls on Wall Street 01/27/21 Facebook - FB BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 01/25/21 Bed Bath & Beyond call volume above normal and directionally bullish 01/25/21 Early notable gainers among liquid option names on January 25th 01/22/21 Bed Bath & Beyond call volume above normal and directionally bullish 01/22/21 Unusually active option classes on open January 22nd BB BlackBerry $18.48 / +0.44 (+2.44%) 01/20/21 Notable open interest changes for January 20th 01/15/21 Unusual call flow in option market yesterday 01/14/21 BlackBerry call volume above normal and directionally bullish 01/11/21 Unusually active option classes on open January 11th FB Facebook $281.99 / +3.98 (+1.43%) 01/15/21 Facebook call volume above normal and directionally bullish 12/21/20 Facebook call buyer realizes 33% same-day gains 12/10/20 Unusually active option classes on open December 10th 12/07/20 Facebook call volume above normal and directionally bullish
Hot Stocks	Twitter acquires newsletter company Revue » 10:39 01/26/21 01/26 10:39 01/26/21 10:39 TWTR Twitter $50.56 / +2.71 (+5.66%) In a company blog post,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TWTR Twitter $50.56 / +2.71 (+5.66%) 01/25/21 Twitter announces proposed settlement of shareholder derivative lawsuits 01/25/21 Twitter introduces Birdwatch community-based approach to misinformation 01/13/21 Twitter CEO says @realDonaldTrump ban 'right decision' for company 01/11/21 Twitter suspends over 70,000 accounts since Friday TWTR Twitter $50.56 / +2.71 (+5.66%) 01/20/21 Piper Sandler Twitter initiated with a Neutral at Piper Sandler 01/19/21 KeyBanc Facebook price target raised to $345 from $340 at KeyBanc 01/13/21 Fly Intel: Top five analyst upgrades 01/13/21 MKM Partners Twitter upgraded to Buy from Neutral at MKM Partners TWTR Twitter $50.56 / +2.71 (+5.66%) 10/29/20 Twitter reports Q3 adjusted EPS 19c, consensus 6c 10/29/20 Notable companies reporting after market close TWTR Twitter $50.56 / +2.71 (+5.66%) 06:06 Today Twitter bans MyPillow CEO on 'repeated violations' of policy, NY Times reports 01/21/21 China state media seeing less 'likes,' or 'retweets,' on Twitter, Newsweek says 01/20/21 Facebook rival MeWe adds 2.5M privacy-seeking users in a week, USA Today says 01/10/21 Airbnb Section 230 use underscores law's reach beyond Facebook, WSJ says TWTR Twitter $50.56 / +2.71 (+5.66%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 01/13/21 Tesla initiation, Home Depot upgrade among today's top calls on Wall Street 02/11/21 Technology & Internet Virtual Conference 02/09/21 Twitter - TWTR 02/25/21 Twitter, Inc. TWTR Twitter $50.56 / +2.71 (+5.66%) 01/20/21 Unusually active option classes on open January 20th 01/12/21 Notable open interest changes for January 12th 12/14/20 Twitter call volume above normal and directionally bullish 12/11/20 Notable open interest changes for December 11th
Hot Stocks	Eli Lilly: Etesevimab, bamlanivimab reduced risk of Covid hospitalizations » 10:38 01/26/21 01/26 10:38 01/26/21 10:38 LLY Eli Lilly $211.92 / -0.58 (-0.27%) , AMGN Amgen $255.50 / -1.24 (-0.48%) Junshi Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 07:24 Today AbCellera announces results from BLAZE-1 trial with Eli Lilly 06:54 Today Eli Lilly announces BLAZE-1 trial meets primary endpoint 01/22/21 Eli Lilly completes acquisition of Prevail Therapeutics 01/21/21 AbCellera-discovered antibody prevented COVID-19 in nursing homes, reduced risks AMGN Amgen $255.50 / -1.24 (-0.48%) 01/21/21 Amgen granted FDA Orphan Drug Designation for carfilzomib 01/11/21 Amgen aims to achieve carbon neutrality by 2027 01/07/21 Moderna announces Corinne Le Goff as chief commercial officer 12/28/20 BeiGene announces three oncology medicines included in NDRL by China NHSA LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 01/20/21 Citi Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data 01/19/21 Roth Capital Merus price target raised to $32 from $19 at Roth Capital 01/19/21 Fly Intel: Top five analyst upgrades 01/19/21 Mizuho Eli Lilly upgraded to Buy from Neutral at Mizuho AMGN Amgen $255.50 / -1.24 (-0.48%) 12/29/20 Daiwa Amgen initiated with a Buy at Daiwa 12/28/20 Oppenheimer Amgen price target lowered to $266 from $274 at Oppenheimer 12/15/20 Goldman Sachs Amgen downgraded to Buy from Conviction Buy at Goldman Sachs 12/09/20 SVB Leerink Amgen price target raised to $253 from $243 at SVB Leerink LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 12/15/20 Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07 12/15/20 Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32 12/02/20 Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c 10/27/20 Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28 AMGN Amgen $255.50 / -1.24 (-0.48%) 10/28/20 Amgen raises FY20 adjusted EPS view to $15.80-$16.15 from $15.10-$15.75 10/28/20 Amgen reports Q3 adjusted EPS $4.37, consensus $3.80 10/28/20 Notable companies reporting after market close 07/28/20 Amgen raises FY20 adjusted EPS view to $15.10-$15.75 from $14.85-$15.60 LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports AMGN Amgen $255.50 / -1.24 (-0.48%) 08/24/20 Salesforce, Amgen, Honeywell to join DJIA index, Bloomberg reports LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday AMGN Amgen $255.50 / -1.24 (-0.48%) 12/16/20 Fly Intel: After-Hours Movers 10/09/20 Fly Intel: Wall Street's top stories for Friday 10/09/20 Fly Intel: Wall Street's top stories at midday 10/09/20 GE reinstatement at Goldman among today's top calls on Wall Street 00:00 Today Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 01/29/21 Eli Lilly - LLY 02/02/21 Amgen - AMGN LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th AMGN Amgen $255.50 / -1.24 (-0.48%) 12/29/20 Early notable gainers among liquid option names on December 29th 08/25/20 Early notable gainers among liquid option names on August 25th 08/25/20 Unusually active option classes on open August 25th
Recommendations	Amarin in 'strong position' against Health Net, says Piper Sandler » 10:35 01/26/21 01/26 10:35 01/26/21 10:35 AMRN Amarin $7.38 / -0.17 (-2.25%) , GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) , TEVA Teva $12.33 / -0.065 (-0.52%) Amarin (AMRN) yesterday… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 10:32 Today Amarin expands Vascepa patent infringement suit to include Health Net 01/21/21 Amarin announces CSC included icosapent ethyl in CD prevention guidelines 01/07/21 Amarin provides outlook on 2021 cash & expenses 12/14/20 Amarin says Vascepa reduced Covid inflammation by 25% in early study GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 01/21/21 Immutep announces GlaxoSmithKline discontinuation of GSK2831781 trial 01/21/21 ViiV Healthcare announces FDA approval of Cabenuva 01/21/21 BiondVax names Amir Reichman as new CEO 01/12/21 Vir Biotechnology, GlaxoSmithKline to evaluate VIR-7832 in COVID-19 patients TEVA Teva $12.33 / -0.065 (-0.52%) 01/15/21 Teva ANDA for Bexarotene approved by FDA 01/14/21 Teva announces availability of generic version of NuvaRing 01/07/21 Teva, MedinCell present results for study on efficacy of schizophrenia treatment 11/27/20 Teva receives tentative approval from FDA for micafungin sodium AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 01/25/21 Cantor Fitzgerald Cantor says Amarin opportunity for Vascepa outside U.S. still 'underappreciated' 01/25/21 Piper Sandler Piper Sandler reiterates 'conviction call' on Amarin into European decision 01/22/21 Cowen Amarin remains undervalued under almost any scenario, says Cowen 01/08/21 Piper Sandler Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 01/20/21 UBS GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS 01/20/21 Fly Intel: Top five analyst downgrades 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse TEVA Teva $12.33 / -0.065 (-0.52%) 12/21/20 Gabelli Teva named 'Best Idea for 2021' at Gabelli 11/27/20 H.C. Wainwright Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright 11/24/20 Oppenheimer Teva initiated with a Perform at Oppenheimer 11/23/20 Citi Citi recommends pair trade of overweight Endo, underweight Teva AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 01/07/21 Amarin sees FY20 revenue up 42% to $610M, consensus $619.19M 11/05/20 Amarin reports Q3 non-GAAP EPS (1c), consensus 1c 08/04/20 Amarin reports Q2 adjusted EPS 4c, consensus (7c) GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% 07/29/20 GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER TEVA Teva $12.33 / -0.065 (-0.52%) 11/05/20 Teva sees FY20 EPS $2.40-$2.55, consensus $2.51 11/05/20 Teva reports Q3 EPS 58c, consensus 58c 08/05/20 Teva reports Q2 EPS 55c, consensus 53c 08/04/20 Notable companies reporting before tomorrow's open AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 11/04/20 Amarin loses bid for rehearing of Vascepa case, Bloomberg says GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says TEVA Teva $12.33 / -0.065 (-0.52%) 11/13/20 Teva facing EU antitrust investigation over Copaxone sales, Bloomberg reports 10/21/20 Purdue Pharma to plead guilty in $8B-plus deal, AP reports 10/02/20 GlaxoSmithKline verdict of $235M against Teva revived on appeal, Bloomberg says 08/25/20 Teva alleged to have overcharged U.S. consumers at least $350M, Bloomberg says AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 01/21/21 Fly Intel: After-Hours Movers 12/14/20 Amarin rises following 'encouraging' results in COVID patients 10/26/20 Fly Intel: Pre-market Movers 10/15/20 Fly Intel: After-Hours Movers GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday TEVA Teva $12.33 / -0.065 (-0.52%) 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Fly Intel: Wall Street's top stories at midday 11/18/20 Fly Intel: After-Hours Movers 08/26/20 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/03/21 GlaxoSmithKline - GSK 02/10/21 Teva - TEVA AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 01/08/21 Amarin call volume above normal and directionally bullish 01/04/21 Amarin call volume above normal and directionally bullish 12/17/20 Amarin call volume above normal and directionally bullish 12/14/20 Unusually active option classes on open December 14th GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish 08/03/20 Unusually active option classes on open August 3rd 07/31/20 Unusually active option classes on open July 31st TEVA Teva $12.33 / -0.065 (-0.52%) 01/19/21 Teva call volume above normal and directionally bullish 01/06/21 Notable open interest changes for January 6th 01/04/21 Teva call volume above normal and directionally bullish 12/23/20 Teva put volume heavy and directionally bearish
Options	Weight Watchers put volume heavy and directionally bearish » 10:35 01/26/21 01/26 10:35 01/26/21 10:35 WW WW $25.00 / +0.04 (+0.16%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals WW WW $25.00 / +0.04 (+0.16%) 01/05/21 The Vitamin Shoppe, WW announce strategic partnership 11/16/20 WW launches new myWW+ with enhancements to app 10/14/20 Zoom Video launches OnZoom a 'marketplace for immersive experiences' 10/14/20 WW collaborates with Zoom Video for launch of OnZoom, Zapps WW WW $25.00 / +0.04 (+0.16%) 12/15/20 Wolfe Research WW initiated with an Outperform at Wolfe Research 12/09/20 DA Davidson WW price target raised to $38 from $33 at DA Davidson 10/09/20 B. Riley Securities Medifast price target raised to $230 from $220 at B. Riley Securities 09/25/20 Citi WW price target lowered to $32 from $35 at Citi WW WW $25.00 / +0.04 (+0.16%) 10/29/20 WW reports Q3 end of period subscribers up 5% year-over-year 10/29/20 WW reports Q3 EPS 78c, consensus 63c 10/29/20 Notable companies reporting after market close 08/04/20 WW reports Q2 EPS 67c, consensus 70c WW WW $25.00 / +0.04 (+0.16%) 08/27/20 Amazon partners with WW for Halo fitness wristband, CNBC reports

General news	Treasury Action: yields are little changed to slightly cheaper » 10:35 01/26/21 01/26 10:35 01/26/21 10:35 Treasury Action: yields… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Freeport McMoRan: Copper sales on track to grow 20% in 2021 vs. 2020 10:34 01/26/21 01/26 10:34 01/26/21 10:34 FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 10:34 Today Freeport McMoRan: Gold sales on track to grow 50% in 2021 vs. 2020 10:26 Today Freeport: Fundamental outlook for copper better than 10 years ago 10:26 Today Freeport: Talking with third party to build Greenfield smelter at alt. location 10:25 Today Freeport McMoRan: Not required to do deals FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 01/20/21 B. Riley Securities Freeport McMoRan price target raised to $32 from $30 at B. Riley Securities 01/13/21 Deutsche Bank Freeport McMoRan price target raised to $33 from $20 at Deutsche Bank 01/05/21 Fly Intel: Top five analyst upgrades 01/05/21 B. Riley Securities Freeport McMoRan price target raised to $30 from $26 at B. Riley Securities FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 08:12 Today Freeport McMoRan reports Q4 adjusted EPS 39c, consensus 38c 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/22/20 Freeport McMoRan reports Q3 EPS 22c, consensus 21c FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 09/16/20 CFO says Freeport not wanting to be 'distracted' by buyout bids, Reuters reports 08/24/20 Workers bar access to Freeport Indonesia's Grasberg mine, Reuters reports FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 11/11/20 Fly Intel: After-Hours Movers 10:00 Today Freeport McMoRan - FCX FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 01/25/21 Freeport McMoRan call volume above normal and directionally bullish 01/07/21 Early notable gainers among liquid option names on January 7th 01/04/21 Early notable gainers among liquid option names on January 4th 12/31/20 Unusually active option classes on open December 31st
Hot Stocks	Freeport McMoRan: Gold sales on track to grow 50% in 2021 vs. 2020 10:34 01/26/21 01/26 10:34 01/26/21 10:34 FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 10:26 Today Freeport: Fundamental outlook for copper better than 10 years ago 10:26 Today Freeport: Talking with third party to build Greenfield smelter at alt. location 10:25 Today Freeport McMoRan: Not required to do deals 10:22 Today Freeport McMoRan to resume cash returns to shareholders during 2021 FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 01/20/21 B. Riley Securities Freeport McMoRan price target raised to $32 from $30 at B. Riley Securities 01/13/21 Deutsche Bank Freeport McMoRan price target raised to $33 from $20 at Deutsche Bank 01/05/21 Fly Intel: Top five analyst upgrades 01/05/21 B. Riley Securities Freeport McMoRan price target raised to $30 from $26 at B. Riley Securities FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 08:12 Today Freeport McMoRan reports Q4 adjusted EPS 39c, consensus 38c 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/22/20 Freeport McMoRan reports Q3 EPS 22c, consensus 21c FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 09/16/20 CFO says Freeport not wanting to be 'distracted' by buyout bids, Reuters reports 08/24/20 Workers bar access to Freeport Indonesia's Grasberg mine, Reuters reports FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 11/11/20 Fly Intel: After-Hours Movers 10:00 Today Freeport McMoRan - FCX FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 01/25/21 Freeport McMoRan call volume above normal and directionally bullish 01/07/21 Early notable gainers among liquid option names on January 7th 01/04/21 Early notable gainers among liquid option names on January 4th 12/31/20 Unusually active option classes on open December 31st
Recommendations	JV doesn't change near-term trajectory for Beyond Meat, says Wells Fargo » 10:33 01/26/21 01/26 10:33 01/26/21 10:33 BYND Beyond Meat $198.20 / +39.49 (+24.88%) , PEP PepsiCo $140.78 / +0.65 (+0.46%) Wells Fargo analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BYND PEP BYND Beyond Meat $198.20 / +39.49 (+24.88%) 09:02 Today Beyond Meat jumps 35% to $215.42 after forming JV with PepsiCo 08:32 Today PepsiCo, Beyond Meat establish The PLANeT Partnership 01/15/21 Beyond Meat announces plans for new global headquarters 01/14/21 Taco Bell exploring new plant-based protein with Beyond Meat PEP PepsiCo $140.78 / +0.65 (+0.46%) 09:02 Today Beyond Meat jumps 35% to $215.42 after forming JV with PepsiCo 08:32 Today PepsiCo, Beyond Meat establish The PLANeT Partnership 12/01/20 PepsiCo, UEFA Champions League continue global partnership 11/24/20 Dick's Sporting names Lauren Hobart as CEO, succeeding Edward Stack BYND PEP BYND Beyond Meat $198.20 / +39.49 (+24.88%) 10:05 Today JPMorgan Beyond Meat move higher should be 'faded,' but maybe not yet, says JPMorgan 09:46 Today Oppenheimer Beyond Meat JV with Pepsi an 'attractive longer-term driver,' says Oppenheimer 01/22/21 Fly Intel: Top five analyst initiations 01/22/21 Longbow Longbow starts Beyond Meat at Neutral due to multiple and near-term uncertainty PEP PepsiCo $140.78 / +0.65 (+0.46%) 10:05 Today JPMorgan Beyond Meat move higher should be 'faded,' but maybe not yet, says JPMorgan 09:46 Today Oppenheimer Beyond Meat JV with Pepsi an 'attractive longer-term driver,' says Oppenheimer 01/19/21 Bernstein PepsiCo initiated with an Underperform at Bernstein 01/06/21 Fly Intel: Top five analyst downgrades BYND PEP BYND Beyond Meat $198.20 / +39.49 (+24.88%) 11/09/20 Beyond Meat reports Q3 adj. EPS (28c), consensus 5c 11/09/20 Notable companies reporting after market close 08/04/20 Beyond Meat 2020 outlook remains suspended 08/04/20 Beyond Meat reports Q2 EPS (2c), consensus (4c) PEP PepsiCo $140.78 / +0.65 (+0.46%) 10/01/20 PepsiCo sees FY core EPS about $5.50, consensus $5.36 10/01/20 PepsiCo reports Q3 adjusted EPS $1.66, consensus $1.49 09/30/20 Notable companies reporting before tomorrow's open 09/30/20 Notable companies reporting before tomorrow's open BYND PEP BYND Beyond Meat $198.20 / +39.49 (+24.88%) 11/09/20 Beyond Meat up 4% after confirming partnership with McDonald's for 'McPlant' 11/09/20 Beyond Meat says co-created 'McPlant' burger with McDonald's, Reuters reports 09/29/20 Chanos says Beyond Meat expansion at Walmart previously announced 09/22/20 Impossible Foods enters Canadian fast casual market, Techcrunch reports PEP PepsiCo $140.78 / +0.65 (+0.46%) 01/15/21 Coca-Cola won't run ads during Super Bowl, Variety reports 09/14/20 PepsiCo to launch Driftwell sleep aid beverage, CNBC reports BYND PEP BYND Beyond Meat $198.20 / +39.49 (+24.88%) 01/20/21 Netflix upgrades, Tesla target hike among today's top calls on Wall Street 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 11/10/20 Fly Intel: Wall Street's top stories for Tuesday 11/10/20 Fly Intel: Wall Street's top stories at midday PEP PepsiCo $140.78 / +0.65 (+0.46%) 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 01/04/21 Airbnb, DoorDash coverage initiations among today's top calls on Wall Street 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 10/12/20 Twitter, Pepsi upgrades among today's top calls on Wall Street 02/11/21 PepsiCo - PEP BYND PEP BYND Beyond Meat $198.20 / +39.49 (+24.88%) 01/25/21 Beyond Meat call volume above normal and directionally bullish 01/22/21 Beyond Meat call volume above normal and directionally bullish 01/13/21 Largest borrow rate increases among liquid names 11/18/20 Unusually active option classes on open November 18th PEP PepsiCo $140.78 / +0.65 (+0.46%) 09:40 Today Unusually active option classes on open January 26th 01/20/21 Unusual call flow in option market yesterday 01/19/21 $1.2M upside call Seller in PepsiCo 09/30/20 Unusually active option classes on open September 30th
Hot Stocks	Amarin expands Vascepa patent infringement suit to include Health Net » 10:32 01/26/21 01/26 10:32 01/26/21 10:32 AMRN Amarin $7.40 / -0.15 (-1.99%) , HKMPF Hikma Pharmaceuticals $0.00 / + (+0.00%) Amarin (AMRN) last night… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMRN HKMPF AMRN Amarin $7.40 / -0.15 (-1.99%) 01/21/21 Amarin announces CSC included icosapent ethyl in CD prevention guidelines 01/07/21 Amarin provides outlook on 2021 cash & expenses 12/14/20 Amarin says Vascepa reduced Covid inflammation by 25% in early study 12/14/20 Amarin announces presentation of Vascepa findings at conference HKMPF Hikma Pharmaceuticals $0.00 / + (+0.00%) 12/17/20 Hikma Pharmaceuticals launches generic Advair Diskus following FDA approval 11/05/20 Hikma Pharmaceuticals launches Icosapent Ethyl capsules in the U.S. 09/03/20 Hikma says 'working towards a launch' of generic version of Amarin's Vascepa 09/03/20 Hikma reports 'favorable court ruling' for generic Vascepa AMRN HKMPF AMRN Amarin $7.40 / -0.15 (-1.99%) 01/25/21 Cantor Fitzgerald Cantor says Amarin opportunity for Vascepa outside U.S. still 'underappreciated' 01/25/21 Piper Sandler Piper Sandler reiterates 'conviction call' on Amarin into European decision 01/22/21 Cowen Amarin remains undervalued under almost any scenario, says Cowen 01/08/21 Piper Sandler Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target HKMPF Hikma Pharmaceuticals $0.00 / + (+0.00%) 01/25/21 Peel Hunt Hikma Pharmaceuticals downgraded to Hold from Buy at Peel Hunt 01/05/21 Citi Underlying trends for Hikma point to upside risks, says Citi 11/24/20 JPMorgan Hikma Pharmaceuticals price target raised to 3,000 GBp from 2,400 GBp at JPMorgan 09/22/20 Morgan Stanley Hikma Pharmaceuticals downgraded to Equal Weight from Overweight at Morgan Stanley AMRN AMRN Amarin $7.40 / -0.15 (-1.99%) 01/07/21 Amarin sees FY20 revenue up 42% to $610M, consensus $619.19M 11/05/20 Amarin reports Q3 non-GAAP EPS (1c), consensus 1c 08/04/20 Amarin reports Q2 adjusted EPS 4c, consensus (7c) AMRN AMRN Amarin $7.40 / -0.15 (-1.99%) 11/04/20 Amarin loses bid for rehearing of Vascepa case, Bloomberg says AMRN AMRN Amarin $7.40 / -0.15 (-1.99%) 01/21/21 Fly Intel: After-Hours Movers 12/14/20 Amarin rises following 'encouraging' results in COVID patients 10/26/20 Fly Intel: Pre-market Movers 10/15/20 Fly Intel: After-Hours Movers 03/01/21 41st Annual Healthcare Virtual Conference AMRN AMRN Amarin $7.40 / -0.15 (-1.99%) 01/08/21 Amarin call volume above normal and directionally bullish 01/04/21 Amarin call volume above normal and directionally bullish 12/17/20 Amarin call volume above normal and directionally bullish 12/14/20 Unusually active option classes on open December 14th

Hot Stocks	Freeport: Fundamental outlook for copper better than 10 years ago 10:26 01/26/21 01/26 10:26 01/26/21 10:26 FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 10:26 Today Freeport: Talking with third party to build Greenfield smelter at alt. location 10:25 Today Freeport McMoRan: Not required to do deals 10:22 Today Freeport McMoRan to resume cash returns to shareholders during 2021 10:05 Today Freeport McMoRan results benefited from improved pricing in both copper and gold FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 01/20/21 B. Riley Securities Freeport McMoRan price target raised to $32 from $30 at B. Riley Securities 01/13/21 Deutsche Bank Freeport McMoRan price target raised to $33 from $20 at Deutsche Bank 01/05/21 Fly Intel: Top five analyst upgrades 01/05/21 B. Riley Securities Freeport McMoRan price target raised to $30 from $26 at B. Riley Securities FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 08:12 Today Freeport McMoRan reports Q4 adjusted EPS 39c, consensus 38c 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/22/20 Freeport McMoRan reports Q3 EPS 22c, consensus 21c FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 09/16/20 CFO says Freeport not wanting to be 'distracted' by buyout bids, Reuters reports 08/24/20 Workers bar access to Freeport Indonesia's Grasberg mine, Reuters reports FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 11/11/20 Fly Intel: After-Hours Movers 10:00 Today Freeport McMoRan - FCX FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 01/25/21 Freeport McMoRan call volume above normal and directionally bullish 01/07/21 Early notable gainers among liquid option names on January 7th 01/04/21 Early notable gainers among liquid option names on January 4th 12/31/20 Unusually active option classes on open December 31st
Hot Stocks	Archer Daniels increases quarterly cash dividend 2.78% to 37c per share » 10:26 01/26/21 01/26 10:26 01/26/21 10:26 ADM Archer Daniels $52.78 / -0.32 (-0.60%) ADM's Board of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ADM Archer Daniels $52.78 / -0.32 (-0.60%) 12/14/20 Calyxt announces sale of 2020 grain production to Archer Daniels 11/04/20 ADM Ventures announces investment in Seventure's HFLC Fund II 10/05/20 ADM, Spiber partner on production of biobased polymers ADM Archer Daniels $52.78 / -0.32 (-0.60%) 01/20/21 Credit Suisse Archer Daniels price target raised to $54 from $46 at Credit Suisse 01/11/21 BMO Capital Archer Daniels downgraded to Market Perform from Outperform at BMO Capital 12/21/20 Barclays Bunge price target raised to $70 from $65 at Barclays 11/09/20 Barclays Archer Daniels price target raised to $55 from $52 at Barclays ADM Archer Daniels $52.78 / -0.32 (-0.60%) 07:14 Today Archer Daniels reports Q4 EPS $1.21, consensus $1.10 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/29/20 Archer Daniels reports Q3 EPS 89c, consensus 71c ADM Archer Daniels $52.78 / -0.32 (-0.60%) 09/17/20 Trump to announce $13B in relief to farmers, Reuters reports ADM Archer Daniels $52.78 / -0.32 (-0.60%) 09:03 Today Fly Intel: Pre-market Movers 10/29/20 Fly Intel: After-Hours Movers 07/29/20 Fly Intel: After-Hours Movers 09:00 Today Archer Daniels - ADM ADM Archer Daniels $52.78 / -0.32 (-0.60%) 10/12/20 Archer Daniels call volume above normal and directionally bullish
Hot Stocks	Freeport: Talking with third party to build Greenfield smelter at alt. location 10:26 01/26/21 01/26 10:26 01/26/21 10:26 FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 10:25 Today Freeport McMoRan: Not required to do deals 10:22 Today Freeport McMoRan to resume cash returns to shareholders during 2021 10:05 Today Freeport McMoRan results benefited from improved pricing in both copper and gold 08:17 Today Freeport McMoRan sees FY21 CapEx $2.3B FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 01/20/21 B. Riley Securities Freeport McMoRan price target raised to $32 from $30 at B. Riley Securities 01/13/21 Deutsche Bank Freeport McMoRan price target raised to $33 from $20 at Deutsche Bank 01/05/21 Fly Intel: Top five analyst upgrades 01/05/21 B. Riley Securities Freeport McMoRan price target raised to $30 from $26 at B. Riley Securities FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 08:12 Today Freeport McMoRan reports Q4 adjusted EPS 39c, consensus 38c 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/22/20 Freeport McMoRan reports Q3 EPS 22c, consensus 21c FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 09/16/20 CFO says Freeport not wanting to be 'distracted' by buyout bids, Reuters reports 08/24/20 Workers bar access to Freeport Indonesia's Grasberg mine, Reuters reports FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 11/11/20 Fly Intel: After-Hours Movers 10:00 Today Freeport McMoRan - FCX FCX Freeport McMoRan $27.87 / -1.12 (-3.86%) 01/25/21 Freeport McMoRan call volume above normal and directionally bullish 01/07/21 Early notable gainers among liquid option names on January 7th 01/04/21 Early notable gainers among liquid option names on January 4th 12/31/20 Unusually active option classes on open December 31st
Hot Stocks	Freeport McMoRan: Not required to do deals 10:25 01/26/21 01/26 10:25 01/26/21 10:25 FCX Freeport McMoRan $27.92 / -1.07 (-3.69%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FCX Freeport McMoRan $27.92 / -1.07 (-3.69%) 10:22 Today Freeport McMoRan to resume cash returns to shareholders during 2021 10:05 Today Freeport McMoRan results benefited from improved pricing in both copper and gold 08:17 Today Freeport McMoRan sees FY21 CapEx $2.3B 08:16 Today Freeport McMoRan sees Q1 gold sales volume 275,000 oz. FCX Freeport McMoRan $27.92 / -1.07 (-3.69%) 01/20/21 B. Riley Securities Freeport McMoRan price target raised to $32 from $30 at B. Riley Securities 01/13/21 Deutsche Bank Freeport McMoRan price target raised to $33 from $20 at Deutsche Bank 01/05/21 Fly Intel: Top five analyst upgrades 01/05/21 B. Riley Securities Freeport McMoRan price target raised to $30 from $26 at B. Riley Securities FCX Freeport McMoRan $27.92 / -1.07 (-3.69%) 08:12 Today Freeport McMoRan reports Q4 adjusted EPS 39c, consensus 38c 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/22/20 Freeport McMoRan reports Q3 EPS 22c, consensus 21c FCX Freeport McMoRan $27.92 / -1.07 (-3.69%) 09/16/20 CFO says Freeport not wanting to be 'distracted' by buyout bids, Reuters reports 08/24/20 Workers bar access to Freeport Indonesia's Grasberg mine, Reuters reports FCX Freeport McMoRan $27.92 / -1.07 (-3.69%) 11/11/20 Fly Intel: After-Hours Movers 10:00 Today Freeport McMoRan - FCX FCX Freeport McMoRan $27.92 / -1.07 (-3.69%) 01/25/21 Freeport McMoRan call volume above normal and directionally bullish 01/07/21 Early notable gainers among liquid option names on January 7th 01/04/21 Early notable gainers among liquid option names on January 4th 12/31/20 Unusually active option classes on open December 31st
General news	U.S. Richmond Fed January manufacturing index dropped -5 points to 14 » 10:25 01/26/21 01/26 10:25 01/26/21 10:25 U.S. Richmond Fed January… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

General news	FX Action: The dollar » 10:25 01/26/21 01/26 10:25 01/26/21 10:25 FX Action: The dollar was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Options	Workhorse Group call volume above normal and directionally bullish » 10:25 01/26/21 01/26 10:25 01/26/21 10:25 WKHS Workhorse Group $29.85 / +5.145 (+20.83%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WKHS Workhorse Group $29.85 / +5.145 (+20.83%) 01/04/21 Workhorse Group receives purchase order from Pride Group Enterprises 12/02/20 USPS says decision on NGDV now planned for Q2 of fiscal 2021 12/02/20 Workhorse sinks 20% after Postal Service again delays vehicle contract 11/23/20 Workhorse Group director sells 99,999 shares of common stock WKHS Workhorse Group $29.85 / +5.145 (+20.83%) 01/04/21 Roth Capital Roth cautious on Workhorse, says order resembles distribution agreement 12/09/20 Wolfe Research Workhorse Group initiated with a Peer Perform at Wolfe Research 12/02/20 Roth Capital USPS delay gives Workhorse competitors more time, says Roth Capital 11/16/20 Lafferty Workhorse Group initiated with a Buy at Lafferty WKHS Workhorse Group $29.85 / +5.145 (+20.83%) 11/09/20 Workhorse Group reports Q3 revenue $565,000, consensus $1.81M 11/09/20 Workhorse Group reports Q3 revenue $565,000, consensus $1.81M 08/10/20 Workhorse Group reports Q2 revenue $92,000, consensus $270,000 WKHS Workhorse Group $29.85 / +5.145 (+20.83%) 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says 12/02/20 USPS again delays mail truck replacement contract, Trucks.com reports 12/01/20 Lucid Motors finishes 1st part of construction on Arizona factory, Electrek says 10/27/20 Lakewood's Bozza pitches Workhorse short at Robinhood event, Bloomberg says WKHS Workhorse Group $29.85 / +5.145 (+20.83%) 01/23/21 Charged: Oppenheimer ups Tesla target to Street-high $1,036 01/09/21 Charged: Apple self-driving EV said to be years away 12/05/20 Charged: Goldman says buy Tesla, USPS delays decision on NGDV 11/30/20 Nikola plunges after new GM agreement includes no stake WKHS Workhorse Group $29.85 / +5.145 (+20.83%) 09:40 Today Unusually active option classes on open January 26th 01/12/21 Largest borrow rate increases among liquid names 12/22/20 Workhorse Group call volume above normal and directionally bullish 12/09/20 Workhorse Group call volume above normal and directionally bullish
Conference/Events	Cowen alternative enery analyst to hold analyst/industry conference call » 10:25 01/26/21 01/26 10:25 01/26/21 10:25 Alternative Energy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Sinclair Broadcast names Jeffrey Lewis as chief compliance officer » 10:23 01/26/21 01/26 10:23 01/26/21 10:23 SBGI Sinclair Broadcast $32.91 / +0.41 (+1.26%) Sinclair Broadcast Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events SBGI Sinclair Broadcast $32.91 / +0.41 (+1.26%) 11/19/20 Bally's, Sinclair announce 10-year sports betting and iGaming partnership 11/04/20 Sinclair Broadcast CEO says Q3 results 'exceeded our expectations' 11/04/20 Sinclair Broadcast reports Q3 consolidated adjusted EBITDA $736M, up 97% y/y 11/04/20 Sinclair Broadcast sees Q4 adjusted EBITDA $586M-$608M SBGI Sinclair Broadcast $32.91 / +0.41 (+1.26%) 12/22/20 Deutsche Bank Sinclair Broadcast resumed with a Hold at Deutsche Bank 12/17/20 Fly Intel: Top five analyst upgrades 12/17/20 Wells Fargo Sinclair Broadcast upgraded to Equal Weight from Underweight at Wells Fargo 11/20/20 Benchmark Sinclair Broadcast price target raised to $35 from $28 at Benchmark SBGI Sinclair Broadcast $32.91 / +0.41 (+1.26%) 11/04/20 Sinclair Broadcast sees Q4 revenue $1.49B-$1.52B, consensus $1.64B 11/04/20 Sinclair Broadcast reports Q3 EPS ($42.66) vs. (64c) a year ago 11/03/20 Notable companies reporting before tomorrow's open 11/03/20 Notable companies reporting before tomorrow's open SBGI Sinclair Broadcast $32.91 / +0.41 (+1.26%) 10/02/20 Supreme Court to hear FCC push to ease media ownership rules, Reuters reports 07/31/20 St. Louis, Milwaukee baseball game delayed for positive COVID tests, AP reports 07/30/20 Blue Jays-Phillies series postponed after positive virus tests, Sportsnet says 07/28/20 Marlins season on pause due to COVID-19 outbreak, Miami Herald reports SBGI Sinclair Broadcast $32.91 / +0.41 (+1.26%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 11/20/20 Bet On It: Ohio and Massachusetts look to establish sports betting market 02/24/21 Sinclair Broadcast - SBGI
Hot Stocks	Freeport McMoRan to resume cash returns to shareholders during 2021 10:22 01/26/21 01/26 10:22 01/26/21 10:22 FCX Freeport McMoRan $28.20 / -0.79 (-2.73%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FCX Freeport McMoRan $28.20 / -0.79 (-2.73%) 10:05 Today Freeport McMoRan results benefited from improved pricing in both copper and gold 08:17 Today Freeport McMoRan sees FY21 CapEx $2.3B 08:16 Today Freeport McMoRan sees Q1 gold sales volume 275,000 oz. 10/22/20 Freeport McMoRan: Makes more sense to develop mines than buy assets FCX Freeport McMoRan $28.20 / -0.79 (-2.73%) 01/20/21 B. Riley Securities Freeport McMoRan price target raised to $32 from $30 at B. Riley Securities 01/13/21 Deutsche Bank Freeport McMoRan price target raised to $33 from $20 at Deutsche Bank 01/05/21 Fly Intel: Top five analyst upgrades 01/05/21 B. Riley Securities Freeport McMoRan price target raised to $30 from $26 at B. Riley Securities FCX Freeport McMoRan $28.20 / -0.79 (-2.73%) 08:12 Today Freeport McMoRan reports Q4 adjusted EPS 39c, consensus 38c 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/22/20 Freeport McMoRan reports Q3 EPS 22c, consensus 21c FCX Freeport McMoRan $28.20 / -0.79 (-2.73%) 09/16/20 CFO says Freeport not wanting to be 'distracted' by buyout bids, Reuters reports 08/24/20 Workers bar access to Freeport Indonesia's Grasberg mine, Reuters reports FCX Freeport McMoRan $28.20 / -0.79 (-2.73%) 11/11/20 Fly Intel: After-Hours Movers 10:00 Today Freeport McMoRan - FCX FCX Freeport McMoRan $28.20 / -0.79 (-2.73%) 01/25/21 Freeport McMoRan call volume above normal and directionally bullish 01/07/21 Early notable gainers among liquid option names on January 7th 01/04/21 Early notable gainers among liquid option names on January 4th 12/31/20 Unusually active option classes on open December 31st

Technical Analysis	NASDAQ market internals summary » 10:17 01/26/21 01/26 10:17 01/26/21 10:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 01/25/21 NASDAQ market internals summary 01/25/21 NASDAQ market internals summary 01/25/21 NASDAQ market internals summary 01/25/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 10:16 01/26/21 01/26 10:16 01/26/21 10:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 01/25/21 NYSE market internals summary 01/25/21 NYSE market internals summary 01/25/21 NYSE market internals summary 01/25/21 NYSE market internals summary
Options	Inseego put volume heavy and directionally bearish » 10:15 01/26/21 01/26 10:15 01/26/21 10:15 INSG Inseego $21.25 / +0.56 (+2.71%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options INSG Inseego $21.25 / +0.56 (+2.71%) 08/10/20 Inseego CEO: Highly secure products are in our DNA 08/06/20 Inseego appoints Craig Foster as CFO 08/05/20 Inseego CFO Steve Smith to step down INSG Inseego $21.25 / +0.56 (+2.71%) 09/04/20 Stifel Inseego 5G opportunity highlighted in meetings with management, says Stifel 08/06/20 Fly Intel: Top five analyst downgrades 08/06/20 Lake Street Inseego price target raised to $17 from $13 at Lake Street 08/06/20 Roth Capital Inseego downgraded to Neutral on valuation at Roth Capital INSG Inseego $21.25 / +0.56 (+2.71%) 11/05/20 Inseego reports Q3 adjusted EPS 1c, consensus (1c) 08/05/20 Inseego reports Q2 EPS (78c) vs. (14c) last year INSG Inseego $21.25 / +0.56 (+2.71%) 09/22/20 Sequans may have lost Verizon as broadband customer, blog author claims INSG Inseego $21.25 / +0.56 (+2.71%) 11/05/20 Fly Intel: After-Hours Movers 08/06/20 Fly Intel: Wall Street's top stories for Thursday 08/06/20 Fly Intel: Wall Street's top stories at midday 03/15/21 33rd Annual Roth Virtual Conference INSG Inseego $21.25 / +0.56 (+2.71%) 09:40 Today Unusually active option classes on open January 26th 12/15/20 Largest borrow rate increases among liquid names 12/14/20 Inseego call volume above normal and directionally bullish 12/11/20 Inseego call volume above normal and directionally bullish
General news	U.S. consumer confidence bounced 2.2 points to 89.3 in January » 10:15 01/26/21 01/26 10:15 01/26/21 10:15 U.S. consumer confidence… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	Richmond Fed Manufacturing Index data reported » 10:05 01/26/21 01/26 10:05 01/26/21 10:05 January Richmond Fed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Events

Earnings calls, analyst events, roadshows and more

Today at 11:00

4-Week Bill Announcement Government Event
Today at 11:00

8-Week Bill Announcement Government Event
CVLG
Today at 11:00

Covenant Logistics - CVLG Conference Calls
GGG
Today at 11:00

Graco - GGG Conference Calls
FFWM
Today at 11:00

First Foundation - FFWM Conference Calls
EFSC
Today at 11:00

Enterprise Financial - EFSC Conference Calls
ELS
Today at 11:00

Equity Lifestyle - ELS Conference Calls
PEBO
Today at 11:00

Peoples Bancorp - PEBO Conference Calls
LMT
Today at 11:00

Lockheed Martin - LMT Conference Calls
BXS
Today at 11:00

BancorpSouth - BXS Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $22.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares
Fri	No deals

View All Syndicate Announcements »

NASDAQ market internals summary

TODAY'S FREE FLY STORIES

Get Full Fly Access